Allocentric Spatial Memory Testing Predicts Conversion from Mild Cognitive Impairment to Dementia: An Initial...

Area of Science:

• Neuroscience
• Gerontology
• Cognitive Psychology

Background:

• The hippocampus is crucial for spatial memory and is an early site of neurodegeneration in Alzheimer's disease (AD).
• Early diagnosis of AD is challenging but vital for timely intervention, especially with emerging disease-modifying therapies.
• The 4 Mountains Test (4MT) is a spatial memory assessment rooted in the cognitive map theory of hippocampal function.

Purpose of the Study:

• To longitudinally assess if allocentric spatial memory, measured by the 4MT, can predict conversion from mild cognitive impairment (MCI) to AD dementia.
• To compare the predictive accuracy of the 4MT with established biomarkers and neuropsychological tests.

Main Methods:

• Fifteen patients with MCI underwent baseline 4MT, cerebrospinal fluid (CSF) amyloid/tau biomarker analysis, volumetric MRI, and neuropsychological tests (RAVLT, TMT-B).
• Patients were followed for 24 months to determine conversion to AD dementia.
• Statistical analyses included predictive accuracy calculations and correlation analyses.

Main Results:

• Nine out of fifteen MCI patients converted to AD dementia within 24 months.
• The 4MT demonstrated high predictive accuracy (93%) for conversion to AD dementia.
• The 4MT outperformed comparator measures including CSF tau/β-amyloid ratio (92%), TMT-B (78%), hippocampal volume (77%), and RAVLT (64%).
• CSF tau levels correlated negatively with 4MT scores (r = -0.71).

Conclusions:

• Allocentric spatial memory testing using the 4MT shows promise as a predictive cognitive biomarker for hippocampal neurodegeneration in early AD.
• The 4MT is a brief, non-invasive, and easily administered test suitable for routine clinical use in early AD diagnosis.
• This translatable biomarker approach can bridge findings between animal models and human subjects for early AD research.